Concorde Asset Management, LLC Protagenic Therapeutics, Inc.New Transaction History

Concorde Asset Management, LLC

  • $149 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022
BUY
$0.57 - $0.8 $2,451 - $3,440
4,300 Added 34.63%
16,718 $10,000
Q2 2022

Aug 05, 2022
BUY
$0.65 - $0.92 $8,071 - $11,424
12,418 New
12,418 $9,000

Others Institutions Holding PTIX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Protagenic Therapeutics, Inc.new

PTIX Quotes by TradingView
  • Ticker PTIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,209,600
  • Market Cap $12.9M
More about PTIX
Track This Portfolio

Track Concorde Asset Management, LLC Portfolio

Follow Concorde Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concorde Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concorde Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email